Amebic Lung Abscess (ICD-11: 1A36.11) - Complete Coding Guide

1. Introduction

Amebic lung abscess is a serious extraintestinal complication of amebiasis, caused by invasion of the protozoan Entamoeba histolytica into lung tissue. This condition represents one of the most serious manifestations of amebic infection, occurring when the parasite disseminates beyond the gastrointestinal tract, its primary site of infection. The clinical importance of this condition lies not only in its potential severity, but also in the need for precise differential diagnosis with other causes of cavitary lung lesions.

The prevalence of pulmonary amebic abscess is significantly lower than amebic hepatic abscess; however, its morbidity and mortality can be considerable when not diagnosed and treated appropriately. This condition generally occurs as direct extension of a hepatic abscess through the diaphragm or, less frequently, by hematogenous dissemination. The right lung is more commonly affected due to anatomical proximity to the right hepatic lobe.

From a public health perspective, pulmonary amebic abscess represents a diagnostic challenge in regions endemic for amebiasis, where it may be confused with pulmonary tuberculosis, bacterial abscesses, or other pneumopathies. Correct coding of this condition in ICD-11 is fundamental to ensure appropriate treatment, allow precise epidemiological studies, facilitate appropriate reimbursement of medical services, and contribute to reliable health statistics. Clear distinction between different extraintestinal manifestations of amebiasis is essential for appropriate clinical management and for adequate resource allocation in health systems.

2. Correct ICD-11 Code

Code: 1A36.11

Description: Amebic abscess of the lung

Parent category: 1A36.1 - Extraintestinal infections by Entamoeba

This specific code was created in ICD-11 to precisely identify the pulmonary location of invasive amebic infection. The hierarchical structure of ICD-11 allows for more logical organization of amebiasis manifestations, clearly differentiating intestinal from extraintestinal forms, and within the latter, specifying the affected organs.

Code 1A36.11 should be used exclusively when there is confirmation of pulmonary abscess caused by Entamoeba histolytica, whether through histopathological, serological, molecular evidence or strong clinical suspicion based on characteristic epidemiological and radiological criteria. The parent category 1A36.1 encompasses all extraintestinal manifestations of amebiasis, recognizing that the parasite can invade various organs beyond the intestine.

Precision in the use of this code is fundamental to distinguish amebic pulmonary abscess from other causes of cavitary pulmonary lesions, such as bacterial abscesses, tuberculosis, neoplasms, or other parasitic infections. This differentiation has direct implications for treatment, since amebic abscess requires specific antiparasitic therapy, usually with metronidazole or tinidazole, unlike the management of conventional bacterial abscesses.

3. When to Use This Code

Scenario 1: Lung Abscess with Concomitant Hepatic Abscess

Patient presents with fever, pleuritic chest pain in the right hemithorax, and productive cough with chocolate-colored sputum. Chest radiography reveals cavitation in the right lower lobe, and abdominal ultrasound identifies hepatic abscess in the right lobe. Serology for E. histolytica is positive with elevated titers. In this scenario, code 1A36.11 is appropriate for the pulmonary component and should be used in conjunction with 1A36.10 for the hepatic abscess.

Scenario 2: Transdiaphragmatic Extension of Hepatic Abscess

Patient with previous diagnosis of amebic hepatic abscess develops progressive respiratory symptoms, including dyspnea, chest pain, and persistent fever. Computed tomography demonstrates extension of the hepatic abscess through the diaphragm with collection formation in the adjacent lung parenchyma. There is evidence of reactive pleural effusion. Code 1A36.11 is indicated to document the pulmonary complication of this amebic infection.

Scenario 3: Isolated Lung Abscess with Serological Evidence

Patient from an endemic area for amebiasis presents with a subacute presentation of fever, cough, and occasional hemoptysis. Chest imaging shows cavitary lesion in the right lung without other systemic alterations. Investigation for tuberculosis is negative, bacterial cultures are sterile, but serology for amebiasis is strongly positive. There is a history of diarrhea several months prior. Code 1A36.11 is appropriate even in the absence of documented hepatic abscess.

Scenario 4: Secondary Amebic Empyema

Patient develops pleural empyema secondary to rupture of amebic lung abscess into the pleural space. Thoracentesis reveals pleural fluid with characteristic chocolate-colored appearance, and molecular analysis identifies E. histolytica. There is evidence of adjacent lung parenchymal destruction. Code 1A36.11 is used to identify the amebic origin of the condition and may be complemented with additional codes for the empyema.

Scenario 5: Amebic Bronchopleural Fistula

Patient with amebic lung abscess develops communication between the abscess and the bronchial tree, resulting in voluminous expectoration of necrotic material and bronchopleural fistula formation. Bronchoscopy confirms the presence of fistula, and serological and molecular studies confirm amebic etiology. Code 1A36.11 adequately documents the amebic nature of the destructive lung lesion.

Scenario 6: Bilateral Lung Abscess from Hematogenous Dissemination

Although rare, an immunocompromised patient develops multiple bilateral lung abscesses from hematogenous dissemination of E. histolytica. There is evidence of concomitant amebic colitis and positivity on specific diagnostic tests. No hepatic abscess is identified. Code 1A36.11 is appropriate to document this disseminated pulmonary manifestation of invasive amebiasis.

4. When NOT to Use This Code

Bacterial Lung Abscess

Do not use code 1A36.11 for lung abscesses of bacterial etiology, even if they occur in patients from endemic areas for amebiasis. Abscesses caused by anaerobic bacteria, Staphylococcus aureus, Klebsiella pneumoniae, or other bacterial pathogens should be coded with appropriate codes for bacterial pulmonary infections, even if they present similar radiological features.

Cavitary Pulmonary Tuberculosis

Pulmonary tuberculosis with cavity formation should not be coded as 1A36.11, even in regions where both conditions are endemic. Differentiation is fundamental, as treatment is completely different. Tuberculosis requires specific prolonged antibiotic regimens, while amebic abscess requires antiparasitic therapy.

Intestinal Amebiasis without Pulmonary Complication

Patients with amebic colitis or amebic dysentery without evidence of pulmonary involvement should not receive code 1A36.11. Intestinal amebiasis has specific codes within the ICD-11 classification and should not be confused with extraintestinal manifestations.

Pulmonary Hydatid Cysts

Cystic pulmonary lesions caused by Echinococcus (echinococcosis) should not be coded as amebic abscess, despite both being parasitic infections. The clinical, radiological characteristics and treatment are distinct.

Hepatic Abscess without Pulmonary Involvement

When there is only amebic hepatic abscess without documented pulmonary extension or complication, the correct code is 1A36.10, not 1A36.11. The presence of isolated reactive pleural effusion without pulmonary parenchymal abscess formation does not justify the use of 1A36.11.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The diagnosis of amebic lung abscess requires a combination of clinical, epidemiological, laboratory, and imaging criteria. Clinically, look for fever, pleuritic chest pain, cough (often productive), dyspnea, and occasionally hemoptysis. Expectoration of chocolate-colored material is highly suggestive.

Investigate epidemiological history: origin from endemic area, previous history of diarrhea or dysentery, poor sanitary conditions. Imaging studies are fundamental: chest radiography showing cavitary lesion (more common in right lower lobe), computed tomography revealing lesion characteristics and its relationship with adjacent structures, especially the liver and diaphragm.

Laboratory confirmation includes serology for E. histolytica (indirect hemagglutination test, ELISA), which is usually positive at high titers in extraintestinal forms. Molecular tests (PCR) can identify parasite DNA in abscess aspirate samples. Image-guided percutaneous aspiration can provide material for analysis, revealing fluid with characteristic chocolate-colored appearance, sterile on bacterial cultures, but with E. histolytica trophozoites occasionally identifiable.

Step 2: Check Specifiers

Assess the severity of the condition: abscess size (small <3cm, medium 3-5cm, large >5cm), presence of complications (pleural rupture, bronchopleural fistula, empyema), respiratory function impairment, need for drainage or surgical intervention.

Determine laterality (right is more common due to hepatic proximity), specific location in the lung (upper, middle, or lower lobes), presence of multiple abscesses versus single lesion. Identify whether there is involvement of other organs, particularly concomitant hepatic abscess, which requires additional coding.

Document symptom duration (acute, subacute, chronic), response to specific antiparasitic treatment, and presence of complicating factors such as immunosuppression, malnutrition, or significant comorbidities.

Step 3: Differentiate from Other Codes

1A36.10 - Amebic abscess of the liver: The key difference is anatomical location. Use 1A36.10 when the abscess is confined to hepatic parenchyma without extension or formation of abscess in the lung. When both are present, use both codes. Hepatic abscess may cause reactive pleural effusion without actual pulmonary abscess, a situation in which only 1A36.10 would be used.

1A36.12 - Cutaneous amebiasis: This condition involves ulcerative skin lesions caused by E. histolytica, typically in the perianal region or in contaminated surgical wounds. The difference is obvious by location and lesion characteristics. Cutaneous amebiasis presents progressive and destructive skin ulcers, without pulmonary involvement.

Differentiation of codes for bacterial lung abscesses is fundamental: the latter usually have more acute onset, positive bacterial cultures, response to conventional antibiotics, and negative serology for amebiasis. Pulmonary tuberculosis presents acid-fast bacilli, different radiological pattern, and response to antituberculous treatment.

Step 4: Required Documentation

Checklist of Mandatory Information:

• Complete clinical history including respiratory symptoms, duration, and progression
• Epidemiological data: origin, travel, sanitary conditions, history of previous diarrhea
• Imaging study results: chest radiography, computed tomography, abdominal ultrasound
• Serological results: type of test, antibody titers against E. histolytica
• Molecular test results if available
• Analysis of aspirated material if procedure performed: macroscopic appearance, microscopy, culture
• Exclusion of differential diagnoses: AFB search, bacterial cultures, other relevant tests
• Precise location: laterality, affected lung lobe, lesion size
• Presence of complications: empyema, fistula, rupture
• Involvement of other organs, especially liver
• Response to specific antiparasitic treatment

Clearly document in the medical record the justification for the diagnosis of amebic lung abscess, differentiating it from other causes of cavitary lung lesions. Document the clinical reasoning that led to the diagnostic conclusion and the criteria used.

6. Complete Practical Example

Clinical Case

A 42-year-old male patient, farmer, presents to the emergency department with a chief complaint of fever for 15 days, associated with right-sided chest pain, productive cough, and progressive dyspnea. He reports that approximately three months ago he had an episode of bloody diarrhea that lasted about one week, treated empirically in the community without specific investigation. Over the last five days, he noticed that his sputum acquired a brownish appearance, similar to "chocolate".

On physical examination, he presents febrile (38.8°C), tachycardic, with diminished breath sounds at the right base and pain on palpation of the right hypochondrium. Chest radiography reveals a cavitary lesion of approximately 6cm in the right lower lobe, with an air-fluid level. Abdominal ultrasound identifies a hepatic abscess in the right lobe, measuring 8cm in diameter.

Computed tomography of the chest and abdomen demonstrates a hepatic abscess in the posterior segment of the right lobe, with elevation of the right hemidiaphragm and a pulmonary abscess in the right lower lobe, suggesting transdiaphragmatic extension. There is a small associated pleural effusion. Serology for E. histolytica (indirect hemagglutination) returns positive with titers of 1:2048 (reference values: <1:128). Acid-fast bacillus search in sputum is negative in three samples, and bacterial cultures of sputum reveal no pathogen growth.

Coding Step by Step

Criteria Analysis:

1. Clinical criteria present: Fever, chest pain, productive cough with characteristic chocolate-colored sputum, dyspnea, previous history of dysentery
2. Epidemiological criteria: Farmer from endemic area, possibly precarious sanitary conditions
3. Imaging criteria: Cavitary pulmonary lesion in the right lower lobe, concomitant hepatic abscess, evidence of transdiaphragmatic extension
4. Laboratory criteria: Highly positive serology for E. histolytica, exclusion of tuberculosis and bacterial infection

Code Selected: 1A36.11 (Amebic abscess of the lung)

Additional Code: 1A36.10 (Amebic abscess of the liver)

Complete Justification:

The patient presents with clinical, epidemiological, and laboratory findings compatible with pulmonary amebic abscess. The history of previous dysentery suggests primary intestinal infection by E. histolytica, followed by hematogenous dissemination to the liver and subsequent extension to the lung. Chocolate-colored sputum is highly characteristic of amebic abscess.

The imaging findings clearly demonstrate both the hepatic and pulmonary abscess, with evidence of transdiaphragmatic extension, the most common mechanism for development of pulmonary amebic abscess. The strongly positive serology confirms E. histolytica infection, and the exclusion of tuberculosis and bacterial infection further supports the diagnosis.

The use of both codes (1A36.11 and 1A36.10) is necessary because there is documented involvement of both organs. Code 1A36.11 specifically documents the pulmonary complication, which has its own prognostic and therapeutic implications, while 1A36.10 records the hepatic component of the infection.

Applicable Complementary Codes:

• Code for pleural effusion (if necessary to document separately)
• Codes for specific symptoms if relevant for complete documentation
• Code for procedures if percutaneous drainage or other interventions were performed

The patient was started on intravenous metronidazole 750mg every 8 hours, with planning for subsequent treatment with paromomycin for elimination of intestinal cysts. The favorable clinical response to specific antiparasitic treatment further corroborates the diagnosis of pulmonary amebic abscess.

7. Related Codes and Differentiation

Within the Same Category

1A36.10: Amebic liver abscess

When to use vs. 1A36.11: Use 1A36.10 when the amebic abscess is confined to the hepatic parenchyma, without evidence of extension or abscess formation in the lung. Hepatic abscess is the most common extraintestinal manifestation of amebiasis, typically located in the right lobe. Patients present with right hypochondrial pain, fever, and painful hepatomegaly.

Main difference: Anatomical location is the fundamental differentiating criterion. Hepatic abscess can cause respiratory symptoms due to diaphragmatic irritation or reactive pleural effusion, but this does not constitute a true pulmonary abscess. The presence of pulmonary parenchymal lesion with abscess formation is necessary to use 1A36.11. When both are present, both codes should be used.

1A36.12: Cutaneous amebiasis

When to use vs. 1A36.11: Cutaneous amebiasis is used for ulcerative skin lesions caused by E. histolytica, most commonly in the perianal, perineal region, or in contaminated surgical wounds. It presents as progressive, painful ulcers with irregular borders and necrotic base.

Main difference: The affected organ is completely different. Cutaneous amebiasis involves the skin and subcutaneous tissue, whereas amebic pulmonary abscess affects the lung parenchyma. Clinical manifestations, complementary diagnostic methods, and local therapeutic approach are distinct. Rarely can a patient have both manifestations simultaneously, a situation in which both codes would be appropriate.

Differential Diagnoses

Bacterial Pulmonary Abscess: Generally has a more acute onset, foul-smelling purulent sputum (different from chocolate-colored appearance), positive cultures for anaerobic bacteria or other pathogens, negative serology for amebiasis, response to conventional antibiotics. Frequently associated with aspiration, necrotizing pneumonia, or sepsis of dental origin.

Cavitary Pulmonary Tuberculosis: Presents with acid-fast bacilli in sputum, positive tuberculin test or IGRA, radiological pattern with predilection for upper lobes, prolonged constitutional symptoms (weight loss, night sweats), response to antituberculous treatment. Differentiation is crucial, especially in areas where both conditions are endemic.

Cavitary Lung Carcinoma: More common in patients with history of smoking, advanced age, absence of significant fever, progressive growth of the lesion, presence of other masses or lymphadenopathy, confirmation by biopsy. Serology for amebiasis is negative.

Pulmonary Hydatid Cysts: Caused by Echinococcus, present with distinct radiological characteristics (meniscus sign, floating membrane), specific serology for echinococcosis, history of contact with dogs in endemic areas, risk of anaphylactic reaction if rupture occurs.

8. Differences with ICD-10

In ICD-10, amebic lung abscess was coded as A06.5 - Amebic pulmonary abscess. The ICD-10 structure grouped the manifestations of amebiasis under code A06, with subdivisions for different locations.

Main changes in ICD-11:

ICD-11 introduced a more refined hierarchical structure, creating category 1A36.1 specifically for extraintestinal infections by Entamoeba, and within this, specific codes for each affected organ (1A36.10 for liver, 1A36.11 for lung, 1A36.12 for skin). This organization allows greater specificity and facilitates epidemiological analysis.

The terminology was updated to "amebic abscess of the lung" instead of "amebic pulmonary abscess," reflecting standardization in nomenclature. ICD-11 also offers better integration with electronic health systems and allows greater granularity in coding complications and comorbidities.

Practical impact of these changes:

Healthcare professionals need to adapt to the new code structure, but greater specificity facilitates clinical documentation and communication between different services. For epidemiological studies, ICD-11 allows more detailed analyses of different extraintestinal manifestations of amebiasis. Health information systems need to be updated to incorporate the new coding, and there may be a transition period where both systems coexist.

9. Frequently Asked Questions

How is pulmonary amebic abscess diagnosed?

Diagnosis is established through a combination of clinical, epidemiological, laboratory, and radiological criteria. Clinically, it is suspected in patients with fever, chest pain, cough, and history of prior diarrhea or origin from an endemic area. Chocolate-colored sputum is highly suggestive. Imaging studies (chest radiography, computed tomography) identify the cavitary lesion, usually in the right lower lobe. Serology for E. histolytica is fundamental, being positive at high titers in most cases. Molecular tests (PCR) can detect parasite DNA. Image-guided percutaneous aspiration can provide material for analysis, revealing sterile chocolate-colored fluid on bacterial cultures. It is essential to exclude tuberculosis and bacterial infection through specific investigations.

Is treatment available in public health systems?

Treatment of pulmonary amebic abscess is based on antiparasitic medications, mainly metronidazole or tinidazole, which are generally available in public health systems in various countries. Metronidazole is a widely used medication, relatively low-cost, and included in essential medication lists of international health organizations. After treatment with medications that eliminate tissue trophozoites, subsequent treatment with paromomycin or another luminal agent is recommended to eliminate intestinal cysts. Availability may vary between different regions and health systems, but basic medications are generally accessible.

How long does treatment last?

Typical treatment of pulmonary amebic abscess consists of metronidazole 750mg three times daily for 7-10 days, or tinidazole in equivalent doses. Severe cases may require initial intravenous treatment. After the acute phase, treatment with a luminal agent (paromomycin, iodoquinol, or diloxanide furoate) is necessary for an additional 7-10 days to eliminate intestinal cysts and prevent relapse. Total treatment duration generally ranges from 2 to 3 weeks. Clinical response is usually evident within 3-5 days of adequate treatment initiation. Large abscesses may require percutaneous or surgical drainage in addition to medical treatment, prolonging the recovery period.

Can this code be used in medical certificates?

Yes, code 1A36.11 can and should be used in medical certificates when appropriate, as it precisely documents the patient's condition. Pulmonary amebic abscess is a serious condition that justifies absence from usual activities during treatment and recovery. The duration of absence depends on the severity of the condition, treatment response, and type of professional activity of the patient. Work requiring significant physical effort may require prolonged absence. Proper coding is important for medical documentation purposes, justification of absence, and, when applicable, for issues related to social security benefits or health insurance.

What is the difference between amebic abscess and bacterial lung abscess?

The fundamental difference lies in the etiological agent: amebic abscess is caused by the protozoan Entamoeba histolytica, while bacterial abscess is caused by bacteria (anaerobes, Staphylococcus, Klebsiella, etc.). Clinically, amebic abscess frequently presents with characteristic chocolate-colored sputum, history of prior diarrhea, and association with hepatic abscess. Bacterial abscess typically has foul-smelling purulent sputum and more acute onset. Laboratorially, amebic abscess has positive serology for E. histolytica and sterile bacterial cultures, while bacterial abscess has positive cultures. Treatment is completely different: antiparasitic agents (metronidazole) for amebic versus antibiotics for bacterial. Differentiation is crucial for proper management.

Is pulmonary amebic abscess always associated with hepatic abscess?

Not necessarily. Although most cases of pulmonary amebic abscess occur through direct extension from a hepatic abscess across the diaphragm, some cases may occur through hematogenous dissemination without identifiable hepatic abscess, or the hepatic abscess may have resolved spontaneously before diagnosis of the pulmonary complication. Studies indicate that approximately 70-80% of cases of pulmonary amebic abscess have concomitant hepatic abscess or documented prior history. Isolated cases of pulmonary abscess without hepatic involvement are less common but possible, especially in immunocompromised patients or those with systemic dissemination.

What are the possible complications of pulmonary amebic abscess?

Complications include rupture of the abscess into the pleural space, causing amebic empyema, which can be extensive and require surgical drainage. Bronchopleural fistula can develop when the abscess communicates with the bronchial tree, resulting in copious expectoration of necrotic material and pneumothorax. Rupture into the pericardium is rare but serious, potentially causing cardiac tamponade. Hematogenous dissemination can lead to abscesses in other organs, including the brain. Respiratory insufficiency can occur in extensive or bilateral cases. Pulmonary hemorrhage is possible from erosion of blood vessels. Secondary bacterial infection may complicate the condition. Prognosis is generally good with early diagnosis and adequate treatment, but complications significantly increase morbidity and mortality.

Is drainage of pulmonary amebic abscess necessary?

Most pulmonary amebic abscesses respond well to medical treatment alone with metronidazole or tinidazole, without need for drainage. Percutaneous or surgical drainage is generally reserved for specific cases: very large abscesses (>10cm), lack of response to medical treatment after 5-7 days, imminent rupture, presence of significant empyema, or when diagnostic uncertainty exists and material is needed for analysis. The decision regarding drainage should be individualized, considering abscess size, location, clinical response to treatment, and presence of complications. When necessary, image-guided percutaneous drainage is generally preferable to open surgery, being less invasive and with lower morbidity.

---

Note: This article is intended for healthcare professionals for educational purposes on diagnostic coding. ICD-11 is in the process of implementation in various global health systems. Always consult local guidelines and the most current versions of the classification for coding in official contexts.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Amebic lung abscess
2. 🔬 PubMed Research on Amebic lung abscess
3. 🌍 WHO Health Topics
4. 📋 CDC - Centers for Disease Control
5. 📊 Clinical Evidence: Amebic lung abscess
6. 📋 Ministry of Health - Brazil
7. 📊 Cochrane Systematic Reviews

References verified on 2026-02-04